Xadago (US WorldMeds, LLC)
Welcome to the PulseAid listing for the Xadago drug offered from US WorldMeds, LLC. This Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | US WorldMeds, LLC |
| NON-PROPRIETARY NAME: | safinamide mesylate |
| SUBSTANCE NAME: | SAFINAMIDE MESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-05-08 |
| END MARKETING DATE: | 0000-00-00 |
Xadago HUMAN PRESCRIPTION DRUG Details:
| Item Description | Xadago from US WorldMeds, LLC |
| LABELER NAME: | US WorldMeds, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2017-05-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 27505-110_672ced04-e7bc-4e28-9935-43de63d2fa2c |
| PRODUCT NDC: | 27505-110 |
| APPLICATION NUMBER: | NDA207145 |
Other SAFINAMIDE MESYLATE Pharmaceutical Manufacturers / Labelers:
